Evidence map›Paper›PMID 30805002›Full record

ArticleInternational journal of microbiology2019

Screening and Antifungal Activity of a

Kátia Santana Cruz, Emerson Silva Lima, Marcia de Jesus Amazonas da Silva, Erica Simplício de Souza, Andreia Montoia, Adrian Martin Pohlit, João Vicente Braga de Souza

Open access · goldAbstract read
In one paragraph

Article in International journal of microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Searching for new antifungals for the treatment of cryptococcosis.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Review
  3. Review
  4. Antifungal activity of liriodenine on clinical strains ofThe journal of venomous animals and toxins including tropical diseases · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kátia Santana CruzPrograma de Pós-Graduação da Rede de Biodiversidade e Biotecnologia da Amazônia Legal-Bionorte, Manaus, Amazonas, Brazil.
Emerson Silva LimaUniversidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Marcia de Jesus Amazonas da SilvaUniversidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Erica Simplício de SouzaUniversidade Estadual do Amazonas, Manaus, Amazonas, Brazil.
Andreia MontoiaUniversidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Adrian Martin PohlitInstituto Nacional de Pesquisas da Amazônia, Manaus, Amazonas, Brazil.ORCID 0000-0002-6793-3759
João Vicente Braga de SouzaInstituto Nacional de Pesquisas da Amazônia, Manaus, Amazonas, Brazil.
Universidade Federal do Amazonas · BRInstituto Nacional de Pesquisas da Amazônia · BRFundação de Medicina Tropical · BRUniversidade do Estado do Amazonas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCryptococcosis is a fungal disease of bad prognosis due to its pathogenicity and the toxicity of the drugs used for its treatment. The aim of this study was to investigate the medicinal potential of carbazole and

methodsMICs were established in accordance with the recommendations of the Clinical and Laboratory Standards Institute for alkaloids and derivatives against

resultsScreening of 11 compounds revealed 8-nitroharmane as a significant inhibitor (MIC 40

conclusionsThe synthetic

Identifiers

PMID30805002
PMCPMC6362477
OpenAlexW2913325591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.